跳至主要内容
临床试验/NCT05107921
NCT05107921招募中2 期

Efficacy of Bromfenac Sodium Hydrate Eye Drops in Children With Familial Exudative Vitreoretinopathy After Diode Laser Photocoagulation

Seoul National University Hospital1 个研究点 分布在 1 个国家目标入组 39 人开始时间: 2021年11月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
招募中
入组人数
39
试验地点
1
主要终点
Macular edema response rate

研究概览

简要总结

This study aims to investigate the efficacy and safety of bromfenac sodium hydrate eye drops in patients with familial exudative vitreoretinopathy receiving diode laser photocoagulation.

详细描述

This study aims to evaluate the presence of macular edema as the primary measure and the presence of conjunctival injection as the secondary measure for the investigation of the efficacy of bromfenac sodium hydrate eye drops in patients with familial exudative vitreoretinopathy receiving diode laser photocoagulation.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
1 Month 至 7 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Newly diagnosed patients with familial exudative vitreoretinopathy
  • Needing diode laser photocoagulation
  • Consent to the study

排除标准

  • History of corneal diseases
  • History of hypersensitivity to bromfenac sodium
  • History of hypersensitivity to non-steroidal anti-inflammatory drugs
  • Progressive ocular infection
  • Liver diseases
  • Hypersensitivity to sulfur dioxide
  • Receiving anti-coagulation drugs
  • History of coagulopathies

研究组 & 干预措施

Bromfenac sodium hydrate eye drops

Experimental

The patients will receive bromfenac sodium hydrate eye drops twice daily for 14 days.

干预措施: Bromfenac Sodium (Drug)

结局指标

主要结局

Macular edema response rate

时间窗: 4 weeks after the diode laser photocoagulation

Presence of macular edema

次要结局

  • Conjunctival injection response rate(4 weeks after the diode laser photocoagulation)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jeong Hun Kim

Professor

Seoul National University Hospital

研究点 (1)

Loading locations...

相似试验